917251-99-1 Usage
General Description
8-bromo-5-fluoroquinoline is a synthetic chemical compound that belongs to the quinoline class. It is a derivative of quinoline, which is an organic compound with a bicyclic structure that contains a benzene ring fused to a pyridine ring. 8-bromo-5-fluoroquinoline is a halogenated quinoline with a bromine atom at the 8th position and a fluorine atom at the 5th position. It is used as a building block in the pharmaceutical industry for the synthesis of various drugs, particularly antimalarial and antibacterial agents. It has also found applications in the field of organic and medicinal chemistry as a reagent and intermediate for the preparation of diverse compounds. The molecular structure and properties of 8-bromo-5-fluoroquinoline make it a valuable tool for drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 917251-99-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,7,2,5 and 1 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 917251-99:
(8*9)+(7*1)+(6*7)+(5*2)+(4*5)+(3*1)+(2*9)+(1*9)=181
181 % 10 = 1
So 917251-99-1 is a valid CAS Registry Number.
917251-99-1Relevant articles and documents
HYDROPYRAZINO[1,2-D][1,4]DIAZEPINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE
-
Page/Page column 19, (2021/05/07)
The present invention relates to compounds of formula (I), wherein R1 to R3 and n are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.
HYDRO-1H-PYRROLO[1,2-A]PYRAZINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE
-
Page/Page column 20; 21, (2021/05/29)
The present invention relates to compounds of formula (I), wherein R1 to R3 and n are as described herein, and their pharmaceutically acceptable salt thereof, and compositions including the compounds and methods of using the compounds.
HYDROPYRAZINO[1,2-B]ISOQUINOLINE COMPOUNDS FOR THE TREATMENT OF AUTOIMMUNE DISEASE
-
Page/Page column 17; 18, (2021/05/21)
The present invention relates to compounds of formula (I), wherein R1 to R3 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods